154 related articles for article (PubMed ID: 32248375)
1. Systemic Inflammation and Outcome in 2295 Patients with Stage I-III Colorectal Cancer from Scotland and Norway: First Results from the ScotScan Colorectal Cancer Group.
Park JH; Fuglestad AJ; Køstner AH; Oliwa A; Graham J; Horgan PG; Roxburgh CSD; Kersten C; McMillan DC
Ann Surg Oncol; 2020 Aug; 27(8):2784-2794. PubMed ID: 32248375
[TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: an analysis of 1700 patients.
Golder AM; McMillan DC; Park JH; Mansouri D; Horgan PG; Roxburgh CS
Br J Cancer; 2021 May; 124(11):1828-1835. PubMed ID: 33762720
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L
BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863
[TBL] [Abstract][Full Text] [Related]
5. Staging the tumor and staging the host: A two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer.
Park JH; Ishizuka M; McSorley ST; Kubota K; Roxburgh CSD; Nagata H; Takagi K; Iwasaki Y; Aoki T; Horgan PG; McMillan DC
Am J Surg; 2018 Sep; 216(3):458-464. PubMed ID: 28967380
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer.
Leitch EF; Chakrabarti M; Crozier JE; McKee RF; Anderson JH; Horgan PG; McMillan DC
Br J Cancer; 2007 Nov; 97(9):1266-70. PubMed ID: 17923866
[TBL] [Abstract][Full Text] [Related]
7. Quantitative data on red cell measures of iron status and their relation to the magnitude of the systemic inflammatory response and survival in patients with colorectal cancer.
McSorley ST; Tham A; Steele CW; Dolan RD; Roxburgh CS; Horgan PG; McMillan DC
Eur J Surg Oncol; 2019 Jul; 45(7):1205-1211. PubMed ID: 30850153
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Follow-Up of Patients Undergoing Resection of TNM Stage I Colorectal Cancer: An Analysis of Tumour and Host Determinants of Outcome.
Mansouri D; Powell AG; Park JH; McMillan DC; Horgan PG
World J Surg; 2016 Jun; 40(6):1485-91. PubMed ID: 26920405
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer.
Suzuki Y; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Kondo T; Kitagawa Y
Ann Surg; 2018 Mar; 267(3):527-531. PubMed ID: 27984214
[TBL] [Abstract][Full Text] [Related]
12. The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.
Patel M; McSorley ST; Park JH; Roxburgh CSD; Edwards J; Horgan PG; McMillan DC
Br J Cancer; 2018 Mar; 118(5):705-712. PubMed ID: 29337962
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.
Inoue Y; Iwata T; Okugawa Y; Kawamoto A; Hiro J; Toiyama Y; Tanaka K; Uchida K; Mohri Y; Miki C; Kusunoki M
Oncology; 2013; 84(2):100-7. PubMed ID: 23147449
[TBL] [Abstract][Full Text] [Related]
14. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.
Tokunaga R; Sakamoto Y; Nakagawa S; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H
Int J Clin Oncol; 2017 Aug; 22(4):740-748. PubMed ID: 28213742
[TBL] [Abstract][Full Text] [Related]
15. GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
Lin WR; Chiang JM; Liang KH; Lim SN; Lai MW; Tsou YK; Hsieh TY; Hsu CK; Yeh CT
Medicine (Baltimore); 2016 Apr; 95(17):e3487. PubMed ID: 27124048
[TBL] [Abstract][Full Text] [Related]
16. Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
Tsuchihashi K; Ito M; Moriwaki T; Fukuoka S; Taniguchi H; Takashima A; Kumekawa Y; Kajiwara T; Yamazaki K; Esaki T; Makiyama A; Denda T; Satake H; Suto T; Sugimoto N; Katsumata K; Ishikawa T; Kashiwada T; Oki E; Komatsu Y; Okuyama H; Sakai D; Ueno H; Tamura T; Yamashita K; Kishimoto J; Shimada Y; Baba E
Clin Colorectal Cancer; 2018 Dec; 17(4):e687-e697. PubMed ID: 30149986
[TBL] [Abstract][Full Text] [Related]
17. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
Rossi S; Basso M; Strippoli A; Schinzari G; D'Argento E; Larocca M; Cassano A; Barone C
Clin Colorectal Cancer; 2017 Dec; 16(4):264-274. PubMed ID: 28412137
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.
Shimura T; Toiyama Y; Saigusa S; Imaoka H; Okigami M; Fujikawa H; Hiro J; Kobayashi M; Ohi M; Araki T; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Int J Clin Oncol; 2017 Aug; 22(4):758-766. PubMed ID: 28299463
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
[TBL] [Abstract][Full Text] [Related]
20. Normocytic anaemia is associated with systemic inflammation and poorer survival in patients with colorectal cancer treated with curative intent.
McSorley ST; Johnstone M; Steele CW; Roxburgh CSD; Horgan PG; McMillan DC; Mansouri D
Int J Colorectal Dis; 2019 Mar; 34(3):401-408. PubMed ID: 30515556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]